Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Therapie|July 29, 2020
The cardiovascular health of prisoners who use cannabis: An exploratory study among hospitalised prisonersMarion Mongiatti, Paule Bayle, Aude Lagarrigue, et al.
Substance Use & Misuse|September 13, 2016
Three Complementary Approaches to Characterize Buprenorphine MisuseCéline Eiden, Erika Nogue, Caroline Diot, et al.
British Journal of Clinical Pharmacology|July 20, 2021
Adverse events of recreational cannabis use reported to the French addictovigilance network (2012-2017)Emilie Bouquet, Stéphanie Pain, Céline Eiden, et al.
Therapie|July 15, 2020
Addictovigilance contribution during COVID-19 epidemic and lockdown in FranceMaryse Lapeyre-Mestre, Alexandra Boucher, Amélie Daveluy, et al.
Psychopharmacology|March 18, 2019
Lack of correlation between the activity of the mesolimbic dopaminergic system and the rewarding properties of pregabalin in mouseBasile Coutens, Lionel Mouledous, Manta Stella, et al.
Pain Physician|January 24, 2013
Doctor shopping reveals geographical variations in opioid abuseSandra Nordmann, Vincent Pradel, Maryse Lapeyre-Mestre, et al.
British Journal of Clinical Pharmacology|March 23, 2022
Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance dataAnne Roussin, Thomas Soeiro, Charlotte Fouque, et al.
The Lancet. Public Health|January 7, 2026
Cocaine use in Europe: the need for cross-sectoral collaboration between security, justice, health, and social systemsMarie Lhosmot-Marquet, Clotilde Champeyrache, Hélène Donnadieu, et al.
Clinical Therapeutics|August 10, 2019
Teaching Basic Knowledge on Substance Use Disorders: The Impact of e-Learning on Health ProfessionalsEmilie Jouanjus, Maryse Lapeyre-Mestre, Matthieu Nodot, et al.
European Journal of Public Health|February 7, 2023
French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory changeAurélie Aquizerate, Edouard-Jules Laforgue, Marion Istvan, et al.
Pageof 5